Single Ascending Dose Study of SRA-444 in Healthy Subjects
Clinical trial NCT00452504 · COMPLETED
Trial details
- NCT number
- NCT00452504
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-02-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.